International SARS control: analysis of European and non-European public health policies

Abstract

Severe acute respiratory syndrome (SARS) is the first new major infectious disease of the 21st century following reports of cases of atypical pneumonia in Vietnam, Hong Kong, and China. By July 11 2003 8437 people had been effected by the disease. Within six months, 813 people died. SARS has spread rapidly across international borders resulting in significant morbidity, widespread public alarm, and economic loss. It is critical to assess the likelihood of similar occurrences and their possible impact on public health and economic performance. Therefore, the following study was carried out in order to analyze existing international guidelines and to elucidate policy diversity within 30 European countries. Results of this study should support international efforts to formulate effective strategies to combat against SARS.